Skip to content
Screener

Income Tax at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$770M+67.4%
Pfizer logo
PfizerPFE
-$407M-389%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$3M+4,520%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$9K+104%

Other financials

Income statement

See full
Revenue$31.7M+556%
Gross profit$9.8M+1,340%
Operating income-$51.0M+19.7%
Net income-$62.8M-6.5%
EPS (diluted)-$0.18-5.9%

Balance sheet

See full
Cash & equivalents$258.6M+4.3%
Total debt$9.5M-83.5%
Total equity$253.9M-31.9%
Total assets$744.5M+15.0%

Cash flow

See full
Operating cash flow-$43.0M+10.8%
CapEx$254.0K+40.3%
Free cash flow-$43.2M+10.6%

Valuation

See full
Market cap$2.15B+168%
Enterprise value$1.9B+211%
P/S12.6×-43.1×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-81%-39.4pp
Net margin-88.2%-42.7pp
FCF margin-75.7%-36.6pp

Returns & leverage

See full
Return on equity-47.8%-9.8pp
Debt / equity-0.1×
Current ratio8.4×-1.0×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:55 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336646
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Other income (expense)5(14)4431,438
Total other (expense) income, net(11,804)4,582(10,288)10,350
Loss before income taxes(62,840)(59,007)(57,443)(112,243)
Provision for income taxes
Net loss$(62,840)$(59,007)$(57,443)$(112,243)
Net loss per share attributable to common stockholders, basic and diluted$(0.18)$(0.17)$(0.17)$(0.33)
Weighted average common shares outstanding, basic and diluted348,770340,746348,055339,685
Comprehensive loss:

Item 1. Financial Statements.

FAQ

What is Nuvation Bio's income tax?
Nuvation Bio (NUVB) reported income tax of $0 in Q2 2026.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Ask your AI about Nuvation Bio's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude